🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To find the highest and/or recommended dose of TROP2-CAR-NK cells combined ...
Status
Active Not Recruiting
Location
MD Anderson Cancer Center
Start Date
2024-12-02
Trial ID
NCT06358430
study evaluates EB-NK-301, an investigational off-the-shelf allogeneic CAR-...
Status
Recruiting
Location
Peking University Shenzhen Hospital
Start Date
2026-03-02
Trial ID
NCT07589530
Treatments Being Tested
To find the recommended dose of an investigational therapy called chimeric ...
Status
Recruiting
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2025-12-19
Trial ID
NCT07101432
Treatments Being Tested
To find the recommended dose of TROP2- CAR-NK given intraperitoneally (dire...
Status
Suspended
Location
M D Anderson Cancer Center
Start Date
2023-10-11
Trial ID
NCT05922930
Treatments Being Tested
This is a phase 1, single-arm, open-label, dose-escalation and dose-expansi...
Status
Not Yet Recruiting
Location
MD Anderson Cancer Center
Start Date
2026-12-31
Trial ID
NCT07631013
Treatments Being Tested
To find the recommended dose of TROP2- CAR-NK cells that can be given to pa...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2023-10-24
Trial ID
NCT06066424
Treatments Being Tested
The goal of this clinical research study is to study the recommended dose o...
Status
Not Yet Recruiting
Location
UT MD Anderson
Start Date
2026-09-01
Trial ID
NCT07509008
Treatments Being Tested
It is a single-center, open-labeled, single-arm, non-randomized investigato...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-08-01
Trial ID
NCT06454890
Treatments Being Tested
The goal of this clinical research study is to find the highest tolerable d...
Status
Not Yet Recruiting
Location
UT MD Anderson
Start Date
2026-10-01
Trial ID
NCT07553390
Treatments Being Tested
This is a Phase I/II study evaluating the intraperitoneal delivery of TROP2...
Status
Suspended
Location
The University of Texas M. D. Anderson Cancer Center
Start Date
2026-05-26
Trial ID
NCT07377526
Treatments Being Tested